Entity

Time filter

Source Type

Boston, MA, United States

Boston University is a private research university located in Boston, Massachusetts. The university is nonsectarian, but is historically affiliated with the United Methodist Church.The university has more than 3,800 faculty members and 33,000 students, and is one of Boston's largest employers. It offers bachelor's degrees, master's degrees, and doctorates, and medical, dental, business, and law degrees through eighteen schools and colleges on two urban campuses. The main campus is situated along the Charles River in Boston's Fenway-Kenmore and Allston neighborhoods, while the Boston University Medical Campus is in Boston's South End neighborhood. BU also operates 75 study abroad programs in more than 33 cities in over twenty countries and has internship opportunities in ten different countries .BU is categorized as an RU/VH Research University in the Carnegie Classification of Institutions of Higher Education. BU is a member of the Boston Consortium for Higher Education and the Association of American Universities.The university counts seven Nobel Laureates including Martin Luther King, Jr. and Elie Wiesel, 35 Pulitzer Prize winners, nine Academy Award winners, Emmy and Tony Award winners among its faculty and alumni. BU also has MacArthur, Sloan, and Guggenheim Fellowship holders as well as American Academy of Arts and science and National Academy of science members among its past and present graduates and faculty.The Boston University Terriers compete in the NCAA's Division I. BU athletic teams compete in the Patriot League, and Hockey East conferences, and their mascot is Rhett the Boston Terrier. Boston University is well known for men's hockey, in which it has won five national championships, most recently in 2009. In 2014, Boston University ranked #100 among all colleges in the United States by average SAT score. Wikipedia.


Zaman M.H.,Boston University
Nature Reviews Cancer | Year: 2013

In the past decade, novel materials, probes and tools have enabled fundamental and applied cancer researchers to take a fresh look at the complex problem of tumour invasion and metastasis. These new tools, which include imaging modalities, controlled but complex in vitro culture conditions, and the ability to model and predict complex processes in vivo, represent an integration of traditional with novel engineering approaches; and their potential effect on quantitatively understanding tumour progression and invasion looks promising. © 2013 Macmillan Publishers Limited. Source


Patent
Boston University and Fraunhofer United States Inc. | Date: 2015-12-04

A dental implant includes an upper connector portion and lower implantation portion, the connector portion receiving a dental crown or similar prosthesis, the implantation portion having rectangular cross section and linear vertical profile with machine taper. An outer surface of the implantation portion provides frictional fit with a correspondingly shaped surrounding bone surface. A bone removal tool includes a hand-held actuator generating high-frequency, small-amplitude vibration, and an attached metal tool tip having elongated head portion and curved neck portion. The head portion has rectangular cross section and linear taper, and an outer surface of the head portion has a saw-toothed grinding pattern for removing bone. The neck portion is dimensioned and configured to establish mechanical resonance of the tool tip including axial reciprocating action of the head portion in response to the actuator vibration.


Provided herein are novel compositions comprising anti-DEspR antibodies and fragments thereof, including fully human, composite engineered human, humanized, monoclonal, and polyclonal anto-DEspR antibodies and fragments thereof, and methods of their use in a variety of therapeutic applications. The compositions comprising the anti-DEspR antibodies and fragments thereof described herein are useful in diagnostic and imaging methods, such as DEspR-targeted molecular imaging of angiogenesis, and for companion diagnostic and/or in vivo-non invasive imaging and/or assessments.


Defined nanoparticle cluster arrays (NCAs) with dimensions up to 25.4 m square are fabricated on a 10 nm gold film using template guided self-assembly. Structural parameters are precisely controlled, allowing systematic variation of the number of nanoparticles in the clusters (n) and edge to edge separation () between 1


Patent
Boston University | Date: 2015-08-05

Disclosed are methods of treating viral disorders via the administration of an inducing agent and an anti-viral agent. In one embodiment, the inducing agent and the anti-viral agent are administered for about five days, and the anti-viral agent is subsequently administered without the inducing agent for an additional period of about sixteen days for a total cycle of about 21 days.

Discover hidden collaborations